GlassScriptPhysician profile
Donald Scot Malay
NPI 1730119785
$4,411.66
in general payments reported to CMS, 2019-2025
13 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $351 · 2021: $608 · 2022: $758 · 2023: $585 · 2024: $365 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.19 |
| Education | $136.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,447.94 | 2019-2025 | Citrefix, 7 X 23mm Citrelock Implant, Infinity |
| Smith+Nephew, INC. | $665.71 | 2019-2025 | Renasys Go V2 Home, Grafix Pl, Collagenase Santyl |
| Wright Medical Technology, INC. | $379.37 | 2019-2020 | |
| Kerecis Limited | $255.54 | 2022 | |
| Organogenesis INC. | $224.66 | 2019 | |
| Paragon 28, INC. | $196.73 | 2024-2025 | Monkey Rings, Mtp |
| Biocomposites INC | $82.24 | 2024 | |
| Medline Industries LP | $44.50 | 2020-2021 | |
| Depuy Synthes Sales INC. | $28.16 | 2025 | Motoband, Va-Lcp, Minibunion |
| Misonix INC | $25.45 | 2021 | |
| Kuros Biosciences USA, INC | $23.94 | 2022 | |
| Integra Lifesciences Corporation | $20.25 | 2021 | |
| Acera Surgical, INC. | $17.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Malay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.